New Delhi: Pluss Advanced Technologies, a venture funded company by Tata Capital Innovations Fund, has received Rs 50 lakh grant under the Millennium Alliance Programme by the Federation of Indian Chambers of Commerce and Industry (FICCI). The grant will be utilised in building capacity amongst Indian hospitals and neonatal care units to tackle Neonatal deaths in India using MiraCradle, an Indian invention to treat newborn babies born with birth asphyxia.
MiraCradle, a neonate cooler (a patent pending), is a CE certified device which is available in over 130 private hospitals in India. It was designed and developed in partnership with Christian Medical College, Vellore which undertook all clinical trials required for product approvals.
Till date, over 5000 new born babies have been treated using this device, giving them the right to live.
“India accounts for more than a quarter (26 per cent) of the world’s neo-natal deaths. The states of Uttar Pradesh, Madhya Pradesh, Rajasthan and Bihar contribute to more than half of newborn deaths in India. We have chosen Rajasthan as the state to create capacity to tackle birth asphyxia”, said Mr Samit Jain, Managing Director, Pluss Advanced Technologies.
“Birth Asphyxia treatment has always been a challenge in India due to imported devices which costs over Rs 15 Lakhs. MiraCradle is the world’s first such affordable device for treatment of birth asphyxia in neonates. We have successfully worked with partners in South Africa and the device is today a standard method of care for birth asphyxia with 4 major government hospitals in South Africa using it. We hope to make this a reality in India too,” he further added.
